PTRK.ST logo
PTRK.ST(PTRK.ST)
$8.88—Stale · unknown old
9/27/26

Physitrack (PTRK.ST)

Sunday
11:40 PM
ThesisDespite potential growth opportunities, increasing competition and a negative net margin are raising concerns among investors about the company's ability to sustain its market…

Revenue Outlook

★ Analysts see FY2027 revenue reaching $16M — +14.4% growth in a single year.

What Moves the Stock

  1. 01Adoption rates of digital health solutions among physical therapy practices
  2. 02Changes in reimbursement policies for telehealth and digital therapy services
  3. 03Partnerships with healthcare systems or insurance providers
  4. 04Technological advancements in rehabilitation tools
  5. 05Subscription fees from healthcare providers (estimated 70%)
  6. 06Licensing fees from software integrations (estimated 20%)
  7. 07Consulting services (estimated 10%)
  8. 08Telehealth expansion in physical therapy
FY2025 Snapshot
EPS
$-0.43
1Y Return
-52.5%

PTRK.ST Chart

7.27.98.69.310.08.88PTRK.ST Daily8.88May '26Jun '26Aug '26Sep '26

My Notes

  • "Management noted, 'While we see growth in user adoption, competitive pressures are intensifying, which may impact our pricing strategy.'"
  • Moat: Physitrack's integration of comprehensive digital solutions for rehabilitation provides a competitive edge…
  • growth - Investors looking for exposure to the expanding digital health market may find Physitrack appealing despite current challenges.
  • Interest rates can impact Physitrack's valuation multiples and the cost of capital for potential acquisitions or investments in technology.
  • Watch on earnings: User growth rate on the platform, Churn rate of healthcare provider subscriptions, Changes in telehealth reimbursement policies.

One Sentence Summary:

Physitrack: the story is balanced — adoption rates of digital health solutions among physical therapy practices.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.